DuPont de Nemours, Inc.
For the period ended Jun 30, 2026. Filed Aug 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 4, 2026
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2026-03-31; filed 2026-05-05.
0001666700-26-000031
Item 1A. Risk FactorsUnregistered Sales of Equity Securities, Use of Proceeds and Purchases of Equity SecuritiesDefaults Upon Senior SecuritiesMine Safety DisclosuresCurrent report: 10-Q
Period ended 2026-06-30; filed 2026-08-04.
0001666700-26-000053
Item 1A. Risk FactorsUnregistered Sales of Equity Securities, Use of Proceeds and Purchases of Equity SecuritiesDefaults Upon Senior SecuritiesMine Safety DisclosuresThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 18 previous paragraphs and 19 current paragraphs.
17 unchanged; 1 reworded; 1 added; 0 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 1 previous and 1 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (1)
Current report
On June 24, 2026, the Company effected the Reverse Stock Split, which impacted the Company’s common stock, par value $0.01 per share, at a ratio of 1-for-3, and amended the Certificate of Incorporation to reflect a corresponding reduction in the number of authorized shares of the Company's common stock. All comparable periods presented have been retrospectively revised to reflect this change.
Reworded paragraphs (1)
Previous wording
In the fourth quarter of 2025, DuPont entered into the Q4 2025 ASR Transaction with one counterparty to repurchase an aggregate of $500 million of common stock under the $2B Authorization. On January 30, 2026, the Q4 2025 ASR Transaction was completed and the remaining 2 million shares were received and retired for a total of 12.2 million shares based on the volume-weighted average stock price of DuPont common stock during the term of the Q4 2025 ASR Transaction, less an agreed upon discount. See Note 14 to the interim Consolidated Financial Statements for additional information.
Current wording
In May 2026, DuPont entered into accelerated share repurchase agreements with one counterparty for repurchase of about $275 million of common stock (the "Q2 26 ASR Transaction"), under the $2B Authorization. Within the same month, the Q2 2026 ASR Transaction was completed. The Q2 2026 ASR transaction resulted in delivery of approximately 1.8 million shares of DuPont common stock at a price per share of $148.91, which were retired immediately and recorded as an increase to accumulated deficit of $270 million in the second quarter of 2026. See Note 14 to the interim Consolidated Financial Statements for additional information.